Literature DB >> 29751878

Primary Biliary Cholangitis and Autoimmune Hepatitis.

Raul S Gonzalez1, Kay Washington2.   

Abstract

Primary biliary cholangitis and autoimmune hepatitis are common autoimmune diseases of the liver. Both have typical clinical presentations, including certain autoantibodies on serologic testing. Histologic features are also often typical: primary biliary cholangitis shows bile duct destruction (sometimes with granulomas), and autoimmune hepatitis shows prominent portal and lobular lymphoplasmacytic inflammation. Both have a wide differential diagnosis, including one another; they may also simultaneously occur within the same patient. Careful use of clinical and histologic criteria may be necessary for diagnosis. First-line therapy is immunosuppression for autoimmune hepatitis and ursodeoxycholic acid for primary biliary cholangitis. Both diseases may progress to cirrhosis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoantibodies; Autoimmune hepatitis; Biliary disease; Chronic hepatitis; Differential diagnosis; Overlap syndrome; Primary biliary cholangitis; Primary biliary cirrhosis

Mesh:

Substances:

Year:  2018        PMID: 29751878     DOI: 10.1016/j.path.2018.02.010

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  7 in total

1.  A Practical Review of Primary Biliary Cholangitis for the Gastroenterologist.

Authors:  Fernanda Q Onofrio; Gideon M Hirschfield; Aliya F Gulamhusein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-03

2.  The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis.

Authors:  Guiqiang Wang; Atsushi Tanaka; Hong Zhao; Jidong Jia; Xiong Ma; Kenichi Harada; Fu-Sheng Wang; Lai Wei; Qixia Wang; Ying Sun; Yuan Hong; Huiying Rao; Cumali Efe; George Lau; Diana Payawal; Rino Gani; Keith Lindor; Wasim Jafri; Masao Omata; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2021-05-04       Impact factor: 6.047

3.  The Potential Effects of Diabetes Mellitus on Liver Fibrosis in Patients with Primary Biliary Cholangitis.

Authors:  Xu Liu; Hongqin Xu; Mengru Zhan; Junqi Niu
Journal:  Med Sci Monit       Date:  2019-08-17

4.  Familial associations between autoimmune hepatitis and primary biliary cholangitis and other autoimmune diseases.

Authors:  Hauke Thomsen; Xinjun Li; Kristina Sundquist; Jan Sundquist; Asta Försti; Kari Hemminki
Journal:  PLoS One       Date:  2020-10-20       Impact factor: 3.240

Review 5.  Roles of Non-Coding RNAs in Primary Biliary Cholangitis.

Authors:  Yaqin Zhang; Ziying Jiao; Mingwei Chen; Bing Shen; Zongwen Shuai
Journal:  Front Mol Biosci       Date:  2022-07-08

Review 6.  Fibrotic Events in the Progression of Cholestatic Liver Disease.

Authors:  Hanghang Wu; Chaobo Chen; Siham Ziani; Leonard J Nelson; Matías A Ávila; Yulia A Nevzorova; Francisco Javier Cubero
Journal:  Cells       Date:  2021-05-05       Impact factor: 6.600

7.  Characteristics and Inpatient Outcomes of Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome.

Authors:  Yi Jiang; Bing-Hong Xu; Brandon Rodgers; Nikolaos Pyrsopoulos
Journal:  J Clin Transl Hepatol       Date:  2021-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.